Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Balchem Corporation (NASDAQ: BCPC) reported fourth quarter 2020 net earnings of $22.2 million, a rise from $20.4 million in Q4 2019. Adjusted net earnings decreased to $26.9 million from $28.4 million. Record quarterly net sales reached $180.7 million, an increase of 8.5% year-over-year. Full-year net earnings were $84.6 million, with adjusted net earnings at $107.8 million. Strong cash flow supported debt repayments totaling $30 million in Q4 and $95 million for the year, lowering net debt to $79 million.
Balchem Corporation (NASDAQ: BCPC) will feature a presentation by Chairman and CEO Ted Harris and CFO Martin Bengtsson during a H.C. Wainwright Fireside Chat on February 24, 2021, starting at 2:00 p.m. (EDT). This event aims to showcase Balchem’s innovative solutions in the health and nutrition sectors.
Balchem develops and markets specialty ingredients across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on enhancing health and well-being globally.
Balchem Corporation (NASDAQ: BCPC) has scheduled a conference call for February 19, 2021, at 11:00 AM ET to discuss its fourth quarter results. The financial results will be released before the market opens on the same day. CEO Ted Harris and CFO Martin Bengtsson will lead the call, which can be accessed via toll-free number 1-877-407-8289. A replay will be available post-call until March 5, 2021. Detailed information can be found on their website at balchem.com.
Balchem Corporation (NASDAQ: BCPC) will present at the Sidoti & Company LLC Virtual Investor Conference on January 13, 2021, starting at 1:45 p.m. EDT. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation.
A recording will be available on the company's website after the event. Balchem specializes in developing and marketing specialty ingredients for various industries, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) announced a dividend of $0.58 per share on December 16, 2020, marking an 11.5% increase from last year. This dividend will be payable on January 22, 2021, to stockholders of record on December 28, 2020. This represents the eleventh consecutive increase in their annual dividend, reflecting the company’s strong financial performance and the Board's confidence in future strategies, according to CEO Ted Harris.
Balchem Corporation (NASDAQ: BCPC) will present at the Stephens Annual Investment Conference 2020 on November 17, 2020, at 2:00 p.m. (EST). The presentation will be led by Chairman and CEO Ted Harris, along with CFO Martin Bengtsson. Interested parties can access presentation materials before the conference via Balchem's investor relations website.
Balchem specializes in developing and marketing ingredients that enhance health and well-being across various industries, including Human Nutrition, Animal Nutrition, and Specialty Products.
Balchem Corporation will present at Baird’s 2020 Global Industrial Conference on November 12, 2020. The presentation, featuring CEO Ted Harris and CFO Martin Bengtsson, is scheduled for 12:50 p.m. EST. Attendees can access presentation materials in advance via the official website.
Balchem Corporation (NASDAQ: BCPC) reported record third quarter net earnings of $21.6 million for 2020, marking a 4.3% increase from 2019. Net sales rose by 10.4% to $175.1 million, driven by growth in Human and Animal Nutrition sectors. Adjusted net earnings reached $26.9 million, up 2.3% year-over-year, with adjusted EBITDA at $44.4 million, a 10.1% increase. Cash flows from operations were $35.4 million and free cash flow was $28.3 million. The company's net debt decreased to $114.6 million. Balchem continues to implement its ERP system and advances its ESG commitments.
Balchem Corporation (NASDAQ: BCPC) announced a conference call scheduled for October 28, 2020, at 11:00 AM ET to discuss its third-quarter results, which will be published before market opening on the same day. The call will be hosted by CEO Ted Harris and CFO Martin Bengtsson, with a replay available until November 11, 2020. The company, known for enhancing health through its specialty ingredients across various sectors, operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation (NASDAQ: BCPC) will present at Morningstar's Management Behind the Moat Conference on September 29, 2020, at 9:00 a.m. EDT. CEO Ted Harris and CFO Martin Bengtsson will lead the presentation. Interested parties can access the presentation materials prior to the event at here.
Balchem focuses on specialty ingredients within three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.